Kawakami Mark 4
4 · Arcadia Biosciences, Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Kawakami Mark
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-02-03$2.49/sh+700$1,743→ 2,681 total
Footnotes (2)
- [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock.
- [F2]The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from August 1, 2022 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower.